BackPrince Pharmaceutical , Ltd. Overview

Prince Pharmaceutical , Ltd. Receivables

Track Prince Pharmaceutical , Ltd.'s receivables ($160M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$156.59M
↑ 5.33% YoYΔ $7.92M vs prior year quarter

Peer trimmed avg / median

Loading

Prince Pharmaceutical , Ltd. Receivables History

Loading

Prince Pharmaceutical , Ltd. vs. peers: Receivables Comparison

Loading

Prince Pharmaceutical , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Prince Pharmaceutical , Ltd. (6935.TWO) FAQ

Prince Pharmaceutical , Ltd. (6935.TWO) currently reports a receivables of $160M as of June 2026. That compares with $150M in the prior-year period — up 5.3% year over year. Use the charts on this page to explore Prince Pharmaceutical , Ltd.'s receivables history and peer comparisons.

Prince Pharmaceutical , Ltd.'s receivables increased from $150M to $160M — a 5.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Prince Pharmaceutical , Ltd. reported $160M in receivables as of June 2026. That compares with $150M in the prior-year period — up 5.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Prince Pharmaceutical , Ltd., and consider following 6935.TWO for alerts when major investors trade the stock.